Related Experiment Video
Updated: Aug 13, 2026

09:35
Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
Insertions/deletions in the antithrombin gene: 3 mutations associated with non-expression
M Daly1, D J Perry, P L Harper
1Department of Haematology, MRC Centre, Cambridge, England.
Thrombosis and Haemostasis
|May 4, 1992
Summary
Three novel mutations causing antithrombin deficiency were identified in individuals with a history of blood clots. These genetic changes lead to reduced antithrombin levels, impacting protein function and potentially increasing clotting risk.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Antithrombin deficiency is a genetic risk factor for thromboembolic disease.
- Investigating the molecular underpinnings of this deficiency is crucial for understanding disease pathogenesis.
Observation:
- Three individuals with suspected antithrombin deficiency were studied.
- Two individuals had a family history of thromboembolic events.
- Reduced functional and immunologic antithrombin levels (approx. 50%) were observed in plasma.
Findings:
- Novel single-base mutations (two insertions, one deletion) were identified in the antithrombin gene.
- These mutations (T insertion at codon 48, A insertion at codon 208, A deletion at codon 370) resulted in frameshifts.
- Mutations led to premature protein translation termination, with no detectable truncated antithrombin in plasma.
Implications:
- These findings elucidate the genetic basis of antithrombin deficiency in the studied cases.
- The lack of detectable truncated protein suggests rapid degradation or impaired secretion.
- Understanding these mutations can aid in diagnosing and managing hereditary thrombophilia.
Related Concept Videos
Mutations
Overview
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Translation
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

